Amphastar Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary

Amphastar Pharmaceuticals,

08/08/2025 05:08

Amphastar Pharmaceuticals Inc AMPH.OQ reported quarterly adjusted earnings of 85 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 94 cents.  The mean expectation of six analysts for the quarter was for earnings of 74 cents per share. Wall Street expected results to range from 61 cents to 82 cents per share.

Revenue fell 4.4% to $174.41 million from a year ago; analysts expected $173.34 million.

Amphastar Pharmaceuticals Inc's reported EPS for the quarter was 64 cents​.

The company reported quarterly net income of $31.03 million.

Amphastar Pharmaceuticals Inc shares had fallen by 9.3% this quarter and lost 43.9% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 0.9% in the last three months.​

In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for Amphastar Pharmaceuticals Inc is $32.50, about 33.5% above its last closing price of $21.62

This summary was machine generated from LSEG data August 8 at 04:08 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
0.74
0.85
Beat
Mar. 31 2025
0.69
0.74
Beat
Dec. 31 2024
0.95
0.92
Missed
Sep. 30 2024
0.99
0.96
Missed